Correlation Between Fidelity Advisor and Software

Can any of the company-specific risk be diversified away by investing in both Fidelity Advisor and Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Advisor and Software into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fidelity Advisor Biotechnology and Software And It, you can compare the effects of market volatilities on Fidelity Advisor and Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Advisor with a short position of Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Advisor and Software.

Diversification Opportunities for Fidelity Advisor and Software

-0.75

Correlation Coefficient

Fidelity Advisor  Software

Pay attention - limited upside

The 3 months correlation between Fidelity and Software is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Advisor Biotechnology and Software And It in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Software And It and Fidelity Advisor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Advisor Biotechnology are associated (or correlated) with Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Software And It has no effect on the direction of Fidelity Advisor i.e., Fidelity Advisor and Software go up and down completely randomly.

Pair Corralation between Fidelity Advisor and Software

Assuming the 90 days horizon Fidelity Advisor Biotechnology is expected to under-perform the Software. But the mutual fund apears to be less risky and, when comparing its historical volatility, Fidelity Advisor Biotechnology is 1.1 times less risky than Software. The mutual fund trades about -0.12 of its potential returns per unit of risk. The Software And It is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2,718  in Software And It on September 25, 2024 and sell it today you would earn a total of  109.00  from holding Software And It or generate 4.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Fidelity Advisor Biotechnology  vs.  Software And It

Fidelity Advisor Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Advisor Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Software And It

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Software And It are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Software is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Fidelity Advisor and Software

The main advantage of trading using opposite Fidelity Advisor and Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Advisor position performs unexpectedly, Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Software will offset losses from the drop in Software's long position.

The idea behind Fidelity Advisor Biotechnology and Software And It pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.